Limb-Girdle muscular dystrophies (LGMD) are a heritable group of genetically determined disorders with a primary involvement of the pelvic or shoulder girdle musculature with partially cardiac manifestation, such as dilated cardiomyopathy (DCM) and life-threatening tachyarrhythmia. We report here that human induced pluripotent stem cell (hiPSC)-derived cardiomyocytes from a patient with LGMD2I and DCM associated with recurrent ventricular tachycardia displayed ion channel dysfunction and abnormality of calcium homeostasis.
D
ilated cardiomyopathy (DCM) is characterized by left ventricular dilation and depressed systolic function. It affects predominantly younger adults and is the most frequent indication for cardiac transplantation. Patients with DCM have a high risk for sudden cardiac death and arrhythmia.
1,2 DCM is characterized by the presence of left ventricular or biventricular dilatation and systolic dysfunction in the absence of abnormal loading conditions (hypertension, valve disease) or coronary artery disease which could explain global systolic impairment. 3, 4 The causes of DCM can be classified as genetic or nongenetic. Idiopathic DCM is considered to be familial in 20% to 35% of cases. [5] [6] [7] [8] Determining the precise gene responsible for familial DCM impacts medical management and allows early differentiation of those at risk. Molecular genetic analyses have uncovered mutations for DCM in >50 genes. 4 Truncating mutations of the titin gene were shown to be present in 25% of familial or severe transplant DCM cases. 9 However, most cases have no specific distinguishing phenotypic features. Identification of other affected family members is, therefore, the most important indicator of a genetic basis, and all patients should undergo a detailed family history covering ≥3 generations. Patients with mutations in the gene encoding lamin A/C frequently present with high rates of conduction system disease, ventricular arrhythmias, and even sudden cardiac death. 10, 11 However, there is a lack of data about the underlying mechanism of conduction disorders in patients with DCM.
DCM is also frequently observed in patients presenting with muscular dystrophy (MD). MD includes >30 different inherited diseases involving progressive weakness and degeneration of skeletal muscle. MDs can be inherited in a dominant or recessive manner or, in many cases, caused by de novo mutations, which are therefore sporadic. 12 For example, Limb-Girdle muscular dystrophy 2I (LGMD2I), a rare muscular disease, is caused by a recessive mutation in FKRP (fukutin-related protein). 13 The defective gene affects predominantly the pelvic or shoulder girdle musculature and in some cases may also affect the heart leading to DCM and life-threatening tachyarrhythmia. Although LGMD2I is rare, DCM and respiratory complications are common in LGMD2I and are the main reason for mortality. [14] [15] [16] There is no specific therapy for LGMD2I because research has been hindered by the relatively low disease prevalence and lack of appropriate models of the diseases. The aims of this study were (1) to generate a cell line from a patient with LGMD2I that can model some phenotypic properties of DCM for mechanistic and therapeutic studies; (2) to uncover the mechanisms underlying the arrhythmogenesis in a patient with LGMD2I and DCM.
For studies on cardiac functions, especially cardiac ion channel functions, human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) offer advantages over heterologous expression systems, like Xenopus oocytes, human embryonic kidney cells, and Chinese Hamster Ovary cells. These cells lack important constituents of cardiac ion channel macromolecular complexes that might be necessary for the normal electrophysiological characteristics. Emerging evidences indicate that the hiPSC-CMs derived from patients with genetic heart diseases recapitulate the phenotype of the disease. [17] [18] [19] Thus, taking into account the hurdle for obtaining human ventricular cardiomyocytes, we used hiPSC-CMs from a DCM patient with a mutation in the FKRP gene to mimic the cardiac phenotype of LGMD2I and compared the electrophysiological characteristics of these cells with cells from healthy donors for explaining the underlying mechanism of recurrent ventricular tachyarrhythmias.
MATERIALS AND METHODS
The data, analytic methods, and study materials will be made available to other researchers for purposes of reproducing the results or replicating the procedure. They will be provided on request to the corresponding author.
The detailed descriptions of the used methods are provided in the Data Supplement.
Ethics Statement
The skin biopsies from 3 healthy donors and a patient with DCM were obtained with written informed consent. 
Clinical Perspective
Limb-Girdle muscular dystrophies are a heritable group of genetically determined disorders with a primary involvement of the pelvic or shoulder girdle musculature with partially cardiac manifestation, such as dilated cardiomyopathy and life-threatening tachyarrhythmia. The underlying mechanisms are not clear. There is no specific therapy for Limb-Girdle muscular dystrophies and the cardiac disorders because research has been hindered by the relatively low disease prevalence and lack of appropriate models of the diseases. In the current study, we demonstrate that induced pluripotent stem cell-derived cardiomyocytes from a patient with Limb-Girdle muscular dystrophies 2I displayed ion channel and calcium handling dysfunctions that might explain the susceptibility of patients to develop ventricular arrhythmia and heart failure. Induced pluripotent stem cells may provide a useful platform for mechanistic and therapeutic studies on the cardiac disorders of Limb-Girdle muscular dystrophies.
Medical Center Göttingen (approval number: 10/9/15) and conducted in accordance with the Helsinki Declaration of 1975, as revised in 1983.
Clinical Data
Skin biopsy was performed in a 51-year-old male white patient with LGMD2I because of homozygous FKRP variant 826C>A (Leu276Ile) and DCM. DCM was diagnosed many years ago, and left ventricular ejection fraction is <30% ( Figure 1B) . The patient shows progressive proximal muscle weakness and is wheelchair bound. He received a implantable cardioverter defibrillator (ICD) 7 years ago for primary prevention of sudden cardiac death. There was no family history of DCM or LGMD2I. The patient was admitted several times to the hospital because of ICD shocks due to ventricular tachycardia.
Generation of hiPSCs
hiPSCs were generated from primary human fibroblasts derived from skin biopsies. The cell lines from the first healthy donor (D1) and patient were generated using lentiviral particles carrying the reverse tetracycline-controlled transactivator (rtTA) and an inducible polycistronic cassette containing the reprogramming factors OCT4, SOX2, KLF4, and c-MYC as previously described. 20, 21 The second (D2) and third (D3) healthy cell lines were generated in feeder-free culture conditions using the integration-free episomal 4-in-1 CoMiP reprogramming plasmid (Addgene, #63726) with the reprogramming factors OCT4, KLF4, SOX2, c-MYC, and short hairpin RNA against p53, as described previously with modifications.
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Generation of hiPSC-CMs
Frozen aliquots of hiPSCs were thawed and cultured without feeder cells and differentiated into hiPSC-CMs as described with some modifications. 23 At 30 to 60 days of culture with basic culture medium, cardiomyocytes were dissociated from 24-well plates for biological studies and plated on matrigelcoated 3.5 cm petri dishes for patch-clamp measurements.
Polymerase Chain Reaction Assays
For quantitative evaluation of the steady-state mRNA expression in hiPSC-CM cultures, total RNA was prepared using the RNeasy mini kit (Qiagen, Hilden, Germany), including DNAse treatment. The expression of the mRNA of the gene of interest relative to the housekeeping gene GAPDH in samples from treated or untreated (control) cells was calculated by the ΔΔCT method, based on the threshold cycle (CT), as fold change=2
, where ΔCT=CT gene of interest −CT GAPDH and Δ(ΔCT)=ΔCT treated −ΔCT Control . 24 From each experiment, the cDNA of 3 cell culture wells were measured as biological replicates of each treatment. Each cell culture well was measured in duplicate as technical replicates.
Immunofluorescence Staining
iPSC-CM were seeded in matrigel-coated 8-well Lab-Tek chambers (BD Biosciences) and incubated with the following primary antibodies at a dilution of 1:200: α-actinin (Sigma Aldrich), troponin T type 2 (Sigma Aldrich), CACNA1C (Alomone Labs), dystroglycan (Merk Millipore, VIA4-1 and IIH6C4), FKRP (Sigma Aldrich), and SCN5A (abcam). Nuclei were stained with Hoechst (Thermo fisher scientific). This was followed by incubation with Alexa Fluor 568-conjugated (Thermo Fisher Scientific) and Alexa Fluor 488-conjugated (Thermo Fisher Scientific) secondary antibodies. Images were recorded with a Zeiss Axio Observer microscope (Zeiss).
Live-Cell Imaging and Image Processing
Live-cell experiments were performed in a Tokai Hit incubation chamber (Tokai Hit, Fujinomiya, Japan) at 37°C and 5% CO 2 on a CSU-X1 Yokogawa spinning disk confocal (Yokogawa Electric Corporation, Tokyo, Japan) on a Nikon-automated Ti-inverted microscope equipped with 60× Plan Apo NA 1.4 objective lens (Nikon, Tokio, Japan), a Hamamatsu C9100-02 EMCCD camera (Hamamatsu Photonics, Hamamatsu, Japan) using Volocity software (PerkinElmer). For analyzing contractions of cells, cell length was manually tracked using the ImageJ software (National Institutes of Health, Bethesda, MD).
Patch-Clamp
Standard patch-clamp recording techniques were used to measure the peak and late I Na , I to , L-type calcium channel currents (I Ca-L ), I Kr , I Ks , action potential (AP) in the whole-cell configuration, and calcium transient. All the experiments were performed at room temperature (22°C-25°C).
Calcium Fluorescence
To measure the intracellular Ca 2+ concentration, cells were loaded with the fluorescent Ca 2+ indicator Fluo-3 AM. Fluorescence is excited by 488 nm and emitted at 520 nm. Changes in intracellular Ca 
Statistical Analysis
The data were analyzed using InStat (GraphPad, San Diego) and SigmaPlot 11.0 (Systat GmbH, Germany). Student t test was used to compare data from DCM cells with that from donor cells. P<0.05 (2-tailed) was considered significant.
RESULTS
Characterization of Patient-Specific hiPSC-CMs
To confirm the successful generation of hiPSC-CMs, protein and mRNA expression was characterized at the beginning (day 0) and at different time points after onset of differentiation by immunostaining and quantitative polymerase chain reaction analysis. The selected iPSC colonies displayed characteristic human embryonic stem cell morphology, exhibited positive immunostaining for embryonic stem cell markers SSEA-3 (StemGent; Figure IB 
Abnormal AP in DCM-hiPSC-CMs
AP characterizations are summarized in Table I in the Data Supplement. Cardiomyocytes of the patient exhib- 
Reduced Sodium Current I Na With Altered Kinetics in DCM-hiPSC-CMs
To uncover the ion channel alterations responsible for the observed AP changes, voltage clamp recordings were performed.
Peak and late sodium current I Na was significantly reduced in DCM cardiomyocytes compared with control cells (peak I Na , −61.3±18.5 pA versus −186.1±25.0 pA; late I Na , 234.0±48.0 versus 587.0±183.0; Figure 5 ; and Figure II in the Data Supplement). Although the activation curves of I Na was only slightly shifted to more positive potentials, the inactivation curve was significantly shifted to more negative potentials (V0.5 DCM −79.3±2.7 mV versus control −71.6±1.5 mV). The recovery of I Na from inactivation was conspicuously decelerated in DCM cardiomyocytes (Tau, 24.3±2. 
Changes in Potassium Channels in DCM-hiPSC-CMs
The transient outward current (I to ), the rapidly delayed rectifier potassium current (I Kr ), and slowly delayed rectifier potassium current (I Ks ) are assessed by using specific blockers. 4-AP, E-4031, and chromanol 293B were used to isolate I to , I Kr , and I Ks , respectively. 
Calcium Handling Alterations in DCM-hiPSC-CMs
To check whether the calcium handling is normal in DCM-hiPSC-CMs, we examined the intracellular calcium concentration. A reduction of systolic and diastolic calcium concentrations was observed (Figure 8 ). These results reveal altered Ca 2+ homeostasis in human DCM cardiomyocytes with FKRP mutation.
Morphology of Cardiomyocytes
We next analyzed the sarcomeric structure of DCM cardiomyocytes by confocal microscopy. At day 30 of differentiation, both control and DCM cardiomyocytes showed expression of structural markers α-actinin, cardiac troponin T, and dystroglycan. Although, the expression level of α-actinin was significantly reduced compared with healthy donor cardiomyocytes (Figure 2C and 2D) , the expression level of cardiac troponin T (Figure 2A and 2B) and dystroglycan was similar (Figure 2E and 2F) . Our findings support a model in which changes in the distribution and expression patterns of cytoskeletal actin suggest that diverse transcriptional and structural defects may also contribute to DCM. DCM-hiPSC-CMs had significantly lager cell size than control hiPSC-CMs ( Figure VIC in the Data Supplement). The contraction frequency tended to be lower in DCM cardiomyocytes compared with control hiPSCCMs ( Figure VIA and VIB in the Data Supplement).
Next-Generation Sequencing
To check whether the FKRP gene mutation exist in the donor cells and SCN5A gene mutation exist in DCM cells, next-generation sequencing was performed in both cell lines. As expected, mutations were detected neither in FKRP gene in the healthy donor nor in SCN5A gene in DCM cells.
To examine possible reasons for dystroglycan and ion channel dysfunctions caused by the FKRP mutation, the expression level of glycosylated α-dystroglycan and SCN5A channels was analyzed by immunostaining. The colocalization of dystroglycan with SCN5A was observed in both donor and DCM cells. But the level of 
. Abnormal action potentials (AP) in human induced pluripotent stem cells-derived cardiomyocytes (hiPSC-CMs) from the Limb-Girdle muscular dystrophy 2I patient with dilated cardiomyopathy (DCM). A, Representative traces of AP in hiPSC-CMs from the healthy donor (control [Ctr]) and patient (DCM). B, Mean values of maximal upstroke velocity of AP (Vmax). C, Mean values of resting potentials (RP). D, Mean values of AP amplitude (APA). E, Mean values of AP duration (APD) at 50% repolarization (APD50). F, Mean values of APD at 90% repolarization (APD90).
Values given are mean±SEM. n indicates number of cells. Considering that all the experiments described above were performed in hiPSC-CMs from 1 healthy donor (D1), some experiments were repeated in hiPSC-CMs from another 2 subjects (D2 and D3). The results from D2 or D3 versus DCM are similar to the results from D1 versus DCM ( Figure VIII and IX in the Data Supplement).
DISCUSSION
We have for the first time generated patient-specific induced pluripotent stem cell-derived cardiomyocytes from a LGMD2I patient with DCM and ventricular tachyarrhythmia carrying a mutation in the FKRP gene. This has allowed revealing electrophysiological and morphological abnormalities of the cardiomyocytes from the patient. We found (1) sodium-, calcium-, and delayed rectifier potassium channel dysfunction; (2) alterations of calcium handling corresponding to Ca ished laminin binding activity, collectively termed dystroglycanopathies. 26 They are a heterogeneous group of autosomal recessive diseases with a wide spectrum of clinical severities. 27, 28 Dystroglycan consists of a heavily glycosylated extracellular α subunit (α-dystroglycan) and a transmembrane β subunit (β-dystroglycan). α-Dystroglycan and β-dystroglycan are encoded by a single gene and post-translationally cleaved to generate the 2 subunits. α-Dystroglycan is a cell surface receptor for several extracellular matrix proteins, such as laminin, agrin, and perlecan in muscle, and neurexin in brain. The transmembrane β-dystroglycan anchors α-dystroglycan at the cell surface and binds intracellularly to dystrophin, which in turn binds to the actin cytoskeleton. Thus, DG functions as a molecular anchor, connecting the extracellular matrix with the cytoskeleton across the plasma membrane in skeletal muscle. 29, 30 Deficiencies of proteins and enzymes involved in the pathways of α-dystroglycan post-translational modification, for example, glycosylation, are chiefly responsible for dystroglycanopathies. The dystroglycanopathies account for the second most common group of MDs, only less frequent than Duchenne muscular dystrophy. Currently, >6 proteins have been identified in dystroglycan glycosylation pathway. FKRP result in 2 distinct allelic diseases: severe congenital muscular dystrophy and LGMD2I. 33 The missense mutation c.826C > A, p.Leu276Ile is particularly common in LGMD2I patients and has been reported to confer a relatively mild phenotype when present in the homozygous state. 13, 28 Previous studies have estimated a broad range of cardiac involvement (10%-60%) in subjects with LGMD2I. 34 Furthermore, the degree of cardiomyopathy does not correlate with the severity of skeletal myopathy. Mechanistic studies on the cardiac diseases in LGMD2I are limited. In this study, we reprogrammed successfully iPS cell lines from a patient carrying the missense mutation c.826C > A in the FKRP gene clinically presenting with LGMD2I and DCM as well as recurrent ventricular arrhythmia and studied the possible abnormalities and the underlying mechanism, especially focusing on the arrhythmogenic mechanisms. On the morphological level, cardiomyocytes showed disturbance of cytoskeletal α actinin in DCM cardiomyocytes compared with healthy cardiomyocytes, which may contribute to DCM. 35 In addition, using confocal microscopy, DCM cardiomyocytes had a lager cell size consistent with the phenotype of DCM.
Electrophysiological analyses revealed a reduced peak and late sodium current in DCM-hiPSC-CMs. The reduction of I Na can be explained by the changed kinetics and mRNA level of sodium channels. The shift to a more positive potential of the activation curve, the shift to a more negative potential of the inactivation curve, and a decelerated recovery curve of I Na as well as reduced mRNA level of SCN5A were in agreement with reduction of I Na . The changes of the channel kinetics and expression level may be caused by different factors (eg, a channel mutation). Mutations in the SCN5A gene have been linked to long-QT syndrome type 3, sick sinus syndrome, Brugada syndrome, and most recently atrial fibrillation. 36 However, next-generation sequencing analysis did not detect any mutations in SCN5A channel in the hiPSCCMs from the patient as cause of the SCN5A channel dysfunction. In recent years, it has become apparent that ion channels are part of large multiprotein complexes. 37 Disruption of any protein member of such a particular ion channel complex has the potential to affect the function and localization of the associated channels.
How an FKRP mutation may exactly lead to SCN5A channel dysfunction remains to be investigated. One potential mechanism might be an impaired interaction of FKRP with dystroglycan. Dystroglycan consists of a heavily glycosylated extracellular α subunit (α-dystroglycan) and a transmembrane β subunit (β-dystroglycan). Thus, dystroglycan functions as a molecular anchor, connecting laminin in the extracellular matrix with the cytoskeleton across the plasma membrane. 29, 30 Because FKRP is involved in phosphorylation of O-linked mannose in α-DG, which is required for laminin binding, FKRP mutations might impair this process. This hypothesis might be supported by the finding that α-dystroglycan is important for sodium channel function in neurons. 38 Therefore, there might be a similar effect of DG on sodium channels in other tissues, including the heart. Furthermore, recent studies have linked SCN5A to structural changes in DCM 39 and reported impaired sodium channel function in a murine model of Duchenne muscular dystrophy. 40 The colocalization of α-dystroglycan and SCN5A detected in our study supports the importance of dystroglycan for normal SCN5A channel functions in cardiac myocytes.
Although an increasing number of SCN5A mutations have now been associated with the development of DCM, the causal relationship between them remains lacking. In this study, the patient carries an FKRP mutation without SCN5A mutation but displayed SCN5A channel dysfunctions, suggesting that the ion channel dysfunction is probably a consequence rather than a cause of DCM. A further interesting finding of our study is the impaired calcium homeostasis in cardiomyocytes from our patient with DCM. We found reduced calcium transient amplitudes compared with control cardiomyocytes and reduced diastolic and systolic calcium levels. Previous studies have observed abnormal Ca 2+ handling in cardiomyocytes from mice. 41 Although imbalances in Ca 2+ homeostasis have been reported as a key characteristic in several cardiomyopathies, 42 it remains to be elucidated whether these abnormalities are secondary to DCM or a causal factor. Although altered calcium transients in cardiomyocytes from patients with DCM using induced pluripotent stem cells are controversially discussed, 35 reduced calcium transients in our study are consistent with the reduced L-type calcium channel currents.
Previous studies have demonstrated that patients with DCM and ventricular tachycardia have loss-offunction mutations in KCNQ1 correlated with reduced I Ks . 43 Therefore, we analyzed K + channel expression and currents in DCM-hiPSC-CMs. PCR analysis showed that the mRNA levels of KCNQ1 (I Ks ), KCNH2 (I Kr ), and KCND3 (I to ) were reduced at day 35 after differentiation, at which time the current measurements were performed. However, the patch-clamp measurements revealed that only I Kr was significantly reduced. This may suggest an additional mechanism that activated I Ks and I to and hence compensated the influence of reduced channel expression on the channel currents. Again, the question remains open whether the observed ion channel defects are primary effects of FKRP mutation or secondary effects resulting from developing cardiac pathology. It is known that heart failure leads to electric remodeling, including impairments of ion channel expression and function. 44 However, transgenic mice with reduced expression of SCN5A in the heart were shown to develop a DCM. 45 These data suggest that ion channel dysfunction may result from and also result in development of the disease. As dysfunctions of different channels coexist in our DCM-hiPSC-CMs, we hypothesize that ion channel dysfunctions probably evolved from structural or functional changes induced by the FKRP mutation and may contribute to electric and contractile dysfunction in our patient.
Ion channel dysfunctions may lead to alteration of APs. Our data did reveal abnormal APs characterized by reduced AP amplitude and Vmax as well as a minor shortening of APD in DCM cardiomyocytes. The reduced AP amplitude and Vmax can be explained by the reduced I Na and I Ca-L . The minor shortening of APD might result from the total effects of reduced I Na , I Ca-L , and I Kr . The reduced inward late I Na and I ca-L can shorten the APD, whereas the reduced outward I kr can prolong the APD. The net effects produced by the inward and outward currents will determine whether the APD is shortened or prolonged. The minor shortening of APD suggests that the effect of reduced inward currents on APD is slightly bigger than that of the reduced outward currents. This might also explain the absence of statistical significance of APD difference between DCM and control cardiomyocytes. Our data are in accordance to previous published AP characteristics of cardiomyocytes from patients with DCM contributed to titin and troponin mutations.
Taken together, the hiPSC-CMs from the patient with LGMD2I and DCM exhibited sodium, calcium, and K + channel dysfunction, leading to reduced amplitude and upstroke velocity of APs as well as diminished Ca 2+ release. The reduced upstroke velocity of APs is expected to impair the conduction of the excitation in the heart and hence might explain the underlying mechanism of rhythm disorder in our patient. The diminished Ca 2+ release may reduce contraction force of cardiomyocytes and induce heart failure.
CONCLUSION
This study demonstrates that hiPSC-CMs from a patient with DCM with FKRP mutation displayed ion channel dysfunction that might explain the susceptibility of our patient to develop ventricular arrhythmia and heart failure. This indicates that hiPSC-CMs may recapitulate phenotypic features of LGMD with DCM and could enable further studies of mechanisms of cardiac electric dysfunction in rare LGMD patients.
Study Limitations
HiPSC-CMs from only 3 healthy donors and 1 patient with DCM were used for this study. hiPSC-CMs possess similarities but also distinct differences in their physiological properties when compared with adult human cardiomyocytes. This potential bias should be considered in the interpretation of experimental data from hiPSC-CMs. Another consideration is that the characteristics of hiPSCCMs may vary with different gene reprogramming, cell culture, and differentiation methods as well as ages (differentiation and culture time) of cells. Because of limited availability of cells, human ventricular cardiomyocytes were not used for comparison in this study. Therefore, we cannot rule out the differences among individuals and between hiPSC-CMs and adult human cardiomyocytes.
